In contrast to the effects of recombinant CXCL1 treatment, CXCL1-downregulation slowed tumour growth (Fig. 2F) and decreased the number of cells that migrated through the membrane with or without Matrigel coating (Fig. 2G, H). This evidence concerns the gene CXCL1 and neoplasm.